Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Shares Outstanding (2020 - 2025)

Rani Therapeutics Holdings (RANI) has 2 years of Shares Outstanding data on record, last reported at $46.9 million in Q2 2021.

  • For Q2 2021, Shares Outstanding changed 0.01% year-over-year to $46.9 million; the TTM value through Jun 2021 reached $46.9 million, changed 0.01%, while the annual FY2020 figure was $46.9 million, N/A changed from the prior year.
  • Shares Outstanding reached $46.9 million in Q2 2021 per RANI's latest filing, roughly flat from $46.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $46.9 million in Q1 2021 and bottomed at $46.9 million in Q2 2020.